D&G Law

Record SEC Settlement for Insider Trading

Two companies related to SAC Capital Advisors just settled insider trading claims with the SEC for $614 million. The SEC’s complaint, filed last fall, alleged the entities traded on insider information relating to clinical drug trials for an Alzheimer’s medication.  The SEC says this is their largest settlement ever of insider trading allegations. http://www.sec.gov/news/press/2013/2013-41.htm